Quintet Private Bank (Europe)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$583K Hold
12,165
0.04% 79
2026
Q1
$447K Hold
12,165
0.03% 83
2025
Q4
$619K Hold
12,165
0.04% 80
2025
Q3
$675K Buy
12,165
+4,852
+66% +$284K 0.04% 84
2025
Q2
$505K Buy
7,313
+62
+0.9% +$4.22K 0.03% 86
2025
Q1
$504K Sell
7,251
-72
-1% -$5.95K 0.03% 94
2024
Q4
$630K Sell
7,323
-3,742
-34% -$405K 0.03% 88
2024
Q3
$1.32M Buy
11,065
+1,676
+18% +$224K 0.08% 72
2024
Q2
$1.57M Sell
9,389
-154
-2% -$20.4K 0.09% 71
2024
Q1
$1.41M Buy
9,543
+5,543
+139% +$660K 0.06% 82
2023
Q4
$414K Hold
4,000
0.03% 90
2023
Q3
$364K Buy
4,000
+1,978
+98% +$174K 0.02% 93
2023
Q2
$161K Buy
+2,022
New +$165K 0.01% 157
2022
Q2
$161K Buy
+2,022
New +$112K 0.01% 157

Other funds holding NVO

Quintet Private Bank (Europe)'s NVO Position: Q2 2026 in Review

Quintet Private Bank (Europe) held its Novo Nordisk (NVO) position steady in Q2 2026 at 12,165 shares worth $583K. The position accounts for 0.04% of the portfolio, ranked #79.

Quintet Private Bank (Europe) first reported a position in NVO in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.57M in Q2 2024. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Quintet Private Bank (Europe) held 12,165 shares of Novo Nordisk worth $583K as of Q2 2026.
  • Quintet Private Bank (Europe) left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.04% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #79 holding.
  • Quintet Private Bank (Europe) first reported a position in Novo Nordisk in Q2 2022 and has held it in 14 quarters since.
  • Quintet Private Bank (Europe)'s Novo Nordisk position peaked at $1.57M in Q2 2024.
  • 516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.